Related Experiment Video
Updated: Jun 27, 2026

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
Published on: October 5, 2015
[A clinical study of tuberculosis infection in systemic lupus erythematosus]
Lu Zhang1, Dong-Xue Wang, Li Ma
1Department of Rheumatology, China-Japan Friendship Hospital, Beijing 100029, China.
Objective:
To investigate the characteristics and related risk factors associated with Tuberculosis(TB) in patients with systemic lupus erythematosus (SLE) who received glucocorticoid and immunosuppressive therapy.
Methods:
Among the 452 SLE patients underwent the treatment of glucocorticoid and immunosuppressive agent, the clinical data was reviewed and summarized retrospectively.
Results:
42 of 452 (9.29%) patients were diagnosed as TB infection.11 patients (23.81%) had exudative pulmonary tuberculosis and 31 patients (73.81%) had extra-pulmonary TB. Statistics of the 31 patients showed that 8 patients (19.05%) had hematogenous disseminated pulmonary tuberculosis; 6 (14.29%) had tuberculo-meningitis; 2 (4.76%) had thoracic cavity TB; 2 (4.76%) had abdominal cavity TB; 1 (2.38%) had crewels; 1 (2.38%) had bone tuberculosis and 1 (2.38%) had nephronophthisis. The focus of infection was not found in 10 patients. Of all 42 patients with TB infection, 38 cases suffered form lupus nephritis, 40 with hypoalbuminosis, 10 with TB history, 14 had leucocytopenia or hyperglycaemia, respectively. The effect of antiTB therapy started up at least 7 days, or in 4 weeks as longest. 2 patients died of hematogenous disseminated pulmonary tuberculosis.
Conclusion:
Under the treatment of glucocorticoid and immunosuppressive agent, TB incidence in patients with SLE is obviously higher than that of common people. Extra-pulmonary TB and serious infection are more frequently. It is shown that those who had lupus nephritis or TB history are more susceptible to TB.
Related Concept Videos
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies